Roles of metabolic compartmentalization by astrocytes and neurons in the pathophysiology and treatment of parkinson's disease

Shinichi Takahashi, Morinobu Seki, Norihiro Suzuki

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Mitochondrial dysfunction has been implicated in the pathogenesis of both idiopathic and familial Parkinson's disease (PD). Dopamine neurons in the substantia nigra exhibit autonomous pacemaking activity to maintain an optimal dopamine concentration in the striatum, resulting in the activation of energy metabolism. ATP production in neuronal cells is dependent on mitochondrial glucose oxidation, and reactive oxygen species (ROS) production associated with neuronal activation might be a major cause of mitochondrial damage in dopamine neurons. Alpha-synuclein, a major component of Lewy bodies, induces mitochondrial damage, and several genes responsible for familial PD encode molecules necessary for normal mitochondrial function. In addition, the auto-oxidation of dopamine produces dopamine quoinone and ROS. Astroglia provide neurons with lactate produced from glucose via glycolysis in response to neuronal activation. The co-activation of the pentose-phosphate pathway (PPP), a shunt pathway of glycolysis, in astroglia plays a pivotal role in protecting neurons against ROS with glutathione peroxidase and the reduced form of glutathione (GSH). In addition to the allosteric regulation of the PPP, which is associated with the activation of glycolysis, the PPP in astroglia can also be activated by ROS through the Kelch-like enoyl-CoA hydratase-associated protein 1 (KeapD/nuclear factor-erythroid 2 p45 subunit-related factor 2 (Nrf2) system. A rate-limiting enzyme of the PPP, glucose-6-phosphate dehydrogenase (G6PDH), is transcriptionally regulated by the Keapl/Nrf2 system, which is a master regulator of phase 2 detoxifying enzymes. ROS is thought to modify the thiol residue of Keapl and to facilitate Nrf2 dissociation from Keapl. Thereafter, Nrf2 translocates into the nucleus where it induces the transcription of G6PDH. The pharmacological activation of the Keapl/Nrf2 PPP in astroglia may provide a novel strategy for preventing the onset and progression of PD.

Original languageEnglish
Pages (from-to)1497-1508
Number of pages12
JournalBrain and Nerve
Volume65
Issue number12
Publication statusPublished - 2013 Dec

Fingerprint

Pentose Phosphate Pathway
Astrocytes
Parkinson Disease
Reactive Oxygen Species
Neurons
Glycolysis
Dopamine
Glucosephosphate Dehydrogenase
Dopaminergic Neurons
GATA1 Transcription Factor
Enoyl-CoA Hydratase
Allosteric Regulation
Lewy Bodies
Glucose
alpha-Synuclein
Substantia Nigra
Enzymes
Glutathione Peroxidase
Sulfhydryl Compounds
Energy Metabolism

Keywords

  • Astroglia
  • Default mode network
  • Glutathione
  • Keapl/nrf2
  • Pacemaking activity
  • Pentose-phosphate pathway

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Roles of metabolic compartmentalization by astrocytes and neurons in the pathophysiology and treatment of parkinson's disease. / Takahashi, Shinichi; Seki, Morinobu; Suzuki, Norihiro.

In: Brain and Nerve, Vol. 65, No. 12, 12.2013, p. 1497-1508.

Research output: Contribution to journalArticle

@article{3f69e2d0fa534398b622950925444267,
title = "Roles of metabolic compartmentalization by astrocytes and neurons in the pathophysiology and treatment of parkinson's disease",
abstract = "Mitochondrial dysfunction has been implicated in the pathogenesis of both idiopathic and familial Parkinson's disease (PD). Dopamine neurons in the substantia nigra exhibit autonomous pacemaking activity to maintain an optimal dopamine concentration in the striatum, resulting in the activation of energy metabolism. ATP production in neuronal cells is dependent on mitochondrial glucose oxidation, and reactive oxygen species (ROS) production associated with neuronal activation might be a major cause of mitochondrial damage in dopamine neurons. Alpha-synuclein, a major component of Lewy bodies, induces mitochondrial damage, and several genes responsible for familial PD encode molecules necessary for normal mitochondrial function. In addition, the auto-oxidation of dopamine produces dopamine quoinone and ROS. Astroglia provide neurons with lactate produced from glucose via glycolysis in response to neuronal activation. The co-activation of the pentose-phosphate pathway (PPP), a shunt pathway of glycolysis, in astroglia plays a pivotal role in protecting neurons against ROS with glutathione peroxidase and the reduced form of glutathione (GSH). In addition to the allosteric regulation of the PPP, which is associated with the activation of glycolysis, the PPP in astroglia can also be activated by ROS through the Kelch-like enoyl-CoA hydratase-associated protein 1 (KeapD/nuclear factor-erythroid 2 p45 subunit-related factor 2 (Nrf2) system. A rate-limiting enzyme of the PPP, glucose-6-phosphate dehydrogenase (G6PDH), is transcriptionally regulated by the Keapl/Nrf2 system, which is a master regulator of phase 2 detoxifying enzymes. ROS is thought to modify the thiol residue of Keapl and to facilitate Nrf2 dissociation from Keapl. Thereafter, Nrf2 translocates into the nucleus where it induces the transcription of G6PDH. The pharmacological activation of the Keapl/Nrf2 PPP in astroglia may provide a novel strategy for preventing the onset and progression of PD.",
keywords = "Astroglia, Default mode network, Glutathione, Keapl/nrf2, Pacemaking activity, Pentose-phosphate pathway",
author = "Shinichi Takahashi and Morinobu Seki and Norihiro Suzuki",
year = "2013",
month = "12",
language = "English",
volume = "65",
pages = "1497--1508",
journal = "Brain and Nerve",
issn = "0006-8969",
publisher = "Igaku-Shoin Ltd",
number = "12",

}

TY - JOUR

T1 - Roles of metabolic compartmentalization by astrocytes and neurons in the pathophysiology and treatment of parkinson's disease

AU - Takahashi, Shinichi

AU - Seki, Morinobu

AU - Suzuki, Norihiro

PY - 2013/12

Y1 - 2013/12

N2 - Mitochondrial dysfunction has been implicated in the pathogenesis of both idiopathic and familial Parkinson's disease (PD). Dopamine neurons in the substantia nigra exhibit autonomous pacemaking activity to maintain an optimal dopamine concentration in the striatum, resulting in the activation of energy metabolism. ATP production in neuronal cells is dependent on mitochondrial glucose oxidation, and reactive oxygen species (ROS) production associated with neuronal activation might be a major cause of mitochondrial damage in dopamine neurons. Alpha-synuclein, a major component of Lewy bodies, induces mitochondrial damage, and several genes responsible for familial PD encode molecules necessary for normal mitochondrial function. In addition, the auto-oxidation of dopamine produces dopamine quoinone and ROS. Astroglia provide neurons with lactate produced from glucose via glycolysis in response to neuronal activation. The co-activation of the pentose-phosphate pathway (PPP), a shunt pathway of glycolysis, in astroglia plays a pivotal role in protecting neurons against ROS with glutathione peroxidase and the reduced form of glutathione (GSH). In addition to the allosteric regulation of the PPP, which is associated with the activation of glycolysis, the PPP in astroglia can also be activated by ROS through the Kelch-like enoyl-CoA hydratase-associated protein 1 (KeapD/nuclear factor-erythroid 2 p45 subunit-related factor 2 (Nrf2) system. A rate-limiting enzyme of the PPP, glucose-6-phosphate dehydrogenase (G6PDH), is transcriptionally regulated by the Keapl/Nrf2 system, which is a master regulator of phase 2 detoxifying enzymes. ROS is thought to modify the thiol residue of Keapl and to facilitate Nrf2 dissociation from Keapl. Thereafter, Nrf2 translocates into the nucleus where it induces the transcription of G6PDH. The pharmacological activation of the Keapl/Nrf2 PPP in astroglia may provide a novel strategy for preventing the onset and progression of PD.

AB - Mitochondrial dysfunction has been implicated in the pathogenesis of both idiopathic and familial Parkinson's disease (PD). Dopamine neurons in the substantia nigra exhibit autonomous pacemaking activity to maintain an optimal dopamine concentration in the striatum, resulting in the activation of energy metabolism. ATP production in neuronal cells is dependent on mitochondrial glucose oxidation, and reactive oxygen species (ROS) production associated with neuronal activation might be a major cause of mitochondrial damage in dopamine neurons. Alpha-synuclein, a major component of Lewy bodies, induces mitochondrial damage, and several genes responsible for familial PD encode molecules necessary for normal mitochondrial function. In addition, the auto-oxidation of dopamine produces dopamine quoinone and ROS. Astroglia provide neurons with lactate produced from glucose via glycolysis in response to neuronal activation. The co-activation of the pentose-phosphate pathway (PPP), a shunt pathway of glycolysis, in astroglia plays a pivotal role in protecting neurons against ROS with glutathione peroxidase and the reduced form of glutathione (GSH). In addition to the allosteric regulation of the PPP, which is associated with the activation of glycolysis, the PPP in astroglia can also be activated by ROS through the Kelch-like enoyl-CoA hydratase-associated protein 1 (KeapD/nuclear factor-erythroid 2 p45 subunit-related factor 2 (Nrf2) system. A rate-limiting enzyme of the PPP, glucose-6-phosphate dehydrogenase (G6PDH), is transcriptionally regulated by the Keapl/Nrf2 system, which is a master regulator of phase 2 detoxifying enzymes. ROS is thought to modify the thiol residue of Keapl and to facilitate Nrf2 dissociation from Keapl. Thereafter, Nrf2 translocates into the nucleus where it induces the transcription of G6PDH. The pharmacological activation of the Keapl/Nrf2 PPP in astroglia may provide a novel strategy for preventing the onset and progression of PD.

KW - Astroglia

KW - Default mode network

KW - Glutathione

KW - Keapl/nrf2

KW - Pacemaking activity

KW - Pentose-phosphate pathway

UR - http://www.scopus.com/inward/record.url?scp=84892376766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892376766&partnerID=8YFLogxK

M3 - Article

C2 - 24323934

AN - SCOPUS:84892376766

VL - 65

SP - 1497

EP - 1508

JO - Brain and Nerve

JF - Brain and Nerve

SN - 0006-8969

IS - 12

ER -